CLINICAL_TRIALS trial_result · 2017-01-26

Clinical Trial Update: MK-0954E Phase III Long-Term Study in Participants With Hypertension (MK-0954E-356) [Phase 3]

A Phase III long-term study of MK-0954E in hypertension has completed and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2017-01-26